USD 35.56
(-5.14%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.15 Billion USD | 5.95% |
2022 | 1.08 Billion USD | 19.95% |
2021 | 906.4 Million USD | -29.88% |
2020 | 1.29 Billion USD | 25.73% |
2019 | 1.02 Billion USD | -1.71% |
2018 | 1.04 Billion USD | 51.9% |
2017 | 688.6 Million USD | 8.32% |
2016 | 635.7 Million USD | -14.93% |
2015 | 747.27 Million USD | 2029.51% |
2014 | 35.09 Million USD | 1.79% |
2013 | 34.47 Million USD | 21.23% |
2012 | 28.43 Million USD | -21.04% |
2011 | 36.01 Million USD | -19.79% |
2010 | 44.9 Million USD | -48.76% |
2009 | 87.63 Million USD | -42.14% |
2008 | 151.45 Million USD | -1.47% |
2007 | 153.7 Million USD | 4.09% |
2006 | 147.67 Million USD | 534.88% |
2005 | 23.25 Million USD | -8.12% |
2004 | 25.31 Million USD | -4.26% |
2003 | 26.44 Million USD | -4.57% |
2002 | 27.7 Million USD | 48.43% |
2001 | 18.66 Million USD | 201.29% |
2000 | 6.19 Million USD | -3.19% |
1999 | 6.4 Million USD | -18.99% |
1998 | 7.9 Million USD | 338.89% |
1997 | 1.8 Million USD | -25.0% |
1996 | 2.4 Million USD | 9.09% |
1995 | 2.2 Million USD | 69.23% |
1994 | 1.3 Million USD | 18.18% |
1993 | 1.1 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 1.23 Billion USD | 7.48% |
2024 Q3 | 1.21 Billion USD | 0.1% |
2024 Q2 | 1.21 Billion USD | -2.21% |
2023 FY | 1.15 Billion USD | 5.95% |
2023 Q1 | 1.06 Billion USD | -1.8% |
2023 Q2 | 1.1 Billion USD | 3.13% |
2023 Q3 | 1.1 Billion USD | 0.26% |
2023 Q4 | 1.15 Billion USD | 4.35% |
2022 Q3 | 1.06 Billion USD | 1.11% |
2022 FY | 1.08 Billion USD | 19.95% |
2022 Q1 | 1.12 Billion USD | 24.12% |
2022 Q4 | 1.08 Billion USD | 2.0% |
2022 Q2 | 1.05 Billion USD | -6.3% |
2021 Q3 | 890.91 Million USD | -34.3% |
2021 Q4 | 906.4 Million USD | 1.74% |
2021 Q1 | 1.3 Billion USD | 0.84% |
2021 FY | 906.4 Million USD | -29.88% |
2021 Q2 | 1.35 Billion USD | 4.04% |
2020 Q4 | 1.29 Billion USD | 10.39% |
2020 FY | 1.29 Billion USD | 25.73% |
2020 Q3 | 1.17 Billion USD | 0.13% |
2020 Q2 | 1.16 Billion USD | 10.15% |
2020 Q1 | 1.06 Billion USD | 3.27% |
2019 Q2 | 1.13 Billion USD | 2.3% |
2019 Q1 | 1.11 Billion USD | 6.38% |
2019 Q4 | 1.02 Billion USD | 1.32% |
2019 Q3 | 1.01 Billion USD | -10.86% |
2019 FY | 1.02 Billion USD | -1.71% |
2018 FY | 1.04 Billion USD | 51.9% |
2018 Q4 | 1.04 Billion USD | 26.68% |
2018 Q3 | 825.7 Million USD | 1.42% |
2018 Q2 | 814.1 Million USD | -8.1% |
2018 Q1 | 885.9 Million USD | 28.65% |
2017 Q1 | 635.71 Million USD | 0.0% |
2017 FY | 688.6 Million USD | 8.32% |
2017 Q4 | 688.6 Million USD | -0.02% |
2017 Q3 | 688.7 Million USD | -0.21% |
2017 Q2 | 690.16 Million USD | 8.56% |
2016 FY | 635.7 Million USD | -14.93% |
2016 Q4 | 635.7 Million USD | -6.52% |
2016 Q2 | 701.1 Million USD | -11.53% |
2016 Q1 | 792.5 Million USD | 6.05% |
2016 Q3 | 680.07 Million USD | -3.0% |
2015 Q4 | 747.27 Million USD | 842.8% |
2015 Q3 | 79.26 Million USD | 75.96% |
2015 Q2 | 45.04 Million USD | 14.41% |
2015 Q1 | 39.37 Million USD | 30.06% |
2015 FY | 747.27 Million USD | 2029.51% |
2014 FY | 35.09 Million USD | 1.79% |
2014 Q4 | 30.27 Million USD | 12.72% |
2014 Q3 | 26.85 Million USD | 4.9% |
2014 Q2 | 25.59 Million USD | -27.05% |
2014 Q1 | 35.09 Million USD | 21.28% |
2013 Q4 | 28.93 Million USD | -2.52% |
2013 FY | 34.47 Million USD | 21.23% |
2013 Q3 | 29.68 Million USD | -4.72% |
2013 Q2 | 31.15 Million USD | -9.63% |
2013 Q1 | 34.47 Million USD | 32.5% |
2012 Q1 | 28.43 Million USD | 15.69% |
2012 Q2 | 24.01 Million USD | -15.57% |
2012 FY | 28.43 Million USD | -21.04% |
2012 Q4 | 26.01 Million USD | -9.36% |
2012 Q3 | 28.7 Million USD | 19.55% |
2011 Q2 | 29.86 Million USD | -17.07% |
2011 Q4 | 24.58 Million USD | -24.24% |
2011 FY | 36.01 Million USD | -19.79% |
2011 Q1 | 36.01 Million USD | 5.31% |
2011 Q3 | 32.44 Million USD | 8.63% |
2010 Q2 | 30.29 Million USD | -32.52% |
2010 Q1 | 44.9 Million USD | -5.41% |
2010 Q4 | 34.2 Million USD | 4.52% |
2010 Q3 | 32.71 Million USD | 7.99% |
2010 FY | 44.9 Million USD | -48.76% |
2009 Q1 | 87.63 Million USD | -2.12% |
2009 Q2 | 70.74 Million USD | -19.27% |
2009 Q3 | 63.69 Million USD | -9.97% |
2009 Q4 | 47.47 Million USD | -25.46% |
2009 FY | 87.63 Million USD | -42.14% |
2008 FY | 151.45 Million USD | -1.47% |
2008 Q3 | 108.78 Million USD | -27.65% |
2008 Q1 | 151.45 Million USD | 0.27% |
2008 Q2 | 150.36 Million USD | -0.72% |
2008 Q4 | 89.53 Million USD | -17.69% |
2007 Q4 | 151.04 Million USD | 0.96% |
2007 Q2 | 151.98 Million USD | -1.12% |
2007 FY | 153.7 Million USD | 4.09% |
2007 Q1 | 153.7 Million USD | -1.16% |
2007 Q3 | 149.6 Million USD | -1.57% |
2006 Q4 | 155.51 Million USD | 0.16% |
2006 Q3 | 155.27 Million USD | 3.63% |
2006 Q2 | 149.83 Million USD | 1.47% |
2006 Q1 | 147.67 Million USD | -2.79% |
2006 FY | 147.67 Million USD | 534.88% |
2005 FY | 23.25 Million USD | -8.12% |
2005 Q4 | 151.9 Million USD | -1.2% |
2005 Q3 | 153.75 Million USD | 510.13% |
2005 Q2 | 25.2 Million USD | 8.35% |
2005 Q1 | 23.25 Million USD | 18.93% |
2004 Q1 | 25.31 Million USD | -8.55% |
2004 FY | 25.31 Million USD | -4.26% |
2004 Q4 | 19.55 Million USD | 8.6% |
2004 Q3 | 18 Million USD | -26.48% |
2004 Q2 | 24.49 Million USD | -3.23% |
2003 FY | 26.44 Million USD | -4.57% |
2003 Q3 | 27.33 Million USD | 10.27% |
2003 Q2 | 24.78 Million USD | -6.27% |
2003 Q1 | 26.44 Million USD | -1.6% |
2003 Q4 | 27.68 Million USD | 1.29% |
2002 Q3 | 29.87 Million USD | 2.05% |
2002 Q2 | 29.27 Million USD | 5.66% |
2002 Q1 | 27.7 Million USD | 10.29% |
2002 FY | 27.7 Million USD | 48.43% |
2002 Q4 | 26.87 Million USD | -10.07% |
2001 Q3 | 23.9 Million USD | 51.23% |
2001 Q2 | 15.8 Million USD | -4.93% |
2001 Q1 | 16.62 Million USD | 29.45% |
2001 FY | 18.66 Million USD | 201.29% |
2001 Q4 | 25.12 Million USD | 5.08% |
2000 Q2 | 6.19 Million USD | 8.54% |
2000 FY | 6.19 Million USD | -3.19% |
2000 Q3 | 15.12 Million USD | 144.14% |
2000 Q4 | 12.84 Million USD | -15.08% |
2000 Q1 | 5.7 Million USD | 24.1% |
1999 Q1 | 4.5 Million USD | -13.46% |
1999 Q4 | 4.6 Million USD | 0.0% |
1999 Q3 | 4.6 Million USD | -28.13% |
1999 FY | 6.4 Million USD | -18.99% |
1999 Q2 | 6.4 Million USD | 42.22% |
1998 Q1 | 4.9 Million USD | 28.95% |
1998 Q3 | 4.8 Million USD | -39.24% |
1998 FY | 7.9 Million USD | 338.89% |
1998 Q4 | 5.2 Million USD | 8.33% |
1998 Q2 | 7.9 Million USD | 61.22% |
1997 Q4 | 3.8 Million USD | 22.58% |
1997 Q2 | 1.8 Million USD | 5.88% |
1997 Q1 | 1.7 Million USD | 13.33% |
1997 FY | 1.8 Million USD | -25.0% |
1997 Q3 | 3.1 Million USD | 72.22% |
1996 Q4 | 1.5 Million USD | -6.25% |
1996 Q2 | 2.4 Million USD | 41.18% |
1996 Q1 | 1.7 Million USD | -41.38% |
1996 FY | 2.4 Million USD | 9.09% |
1996 Q3 | 1.6 Million USD | -33.33% |
1995 Q3 | 2.3 Million USD | 4.55% |
1995 FY | 2.2 Million USD | 69.23% |
1995 Q1 | 1.1 Million USD | -8.33% |
1995 Q2 | 2.2 Million USD | 100.0% |
1995 Q4 | 2.9 Million USD | 26.09% |
1994 Q2 | 1.3 Million USD | 0.0% |
1994 Q1 | 1.3 Million USD | 8.33% |
1994 Q3 | 1.1 Million USD | -15.38% |
1994 FY | 1.3 Million USD | 18.18% |
1994 Q4 | 1.2 Million USD | 9.09% |
1993 Q3 | 1.2 Million USD | 9.09% |
1993 Q4 | 1.2 Million USD | 0.0% |
1993 Q1 | 1.1 Million USD | 0.0% |
1993 Q2 | 1.1 Million USD | 0.0% |
1993 FY | 1.1 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 51.25 Million USD | -2147.503% |
BrainsWay Ltd. | 15.31 Million USD | -7422.104% |
Cerus Corporation | 144.3 Million USD | -698.27% |
Envoy Medical, Inc. | 9.4 Million USD | -12152.021% |
electroCore, Inc. | 8.94 Million USD | -12777.977% |
Helius Medical Technologies, Inc. | 5.34 Million USD | -21463.74% |
IceCure Medical Ltd | 4.24 Million USD | -27023.499% |
Inogen, Inc. | 121.38 Million USD | -849.016% |
OrthoPediatrics Corp. | 72.56 Million USD | -1487.54% |
Lucid Diagnostics Inc. | 29.58 Million USD | -3794.172% |
Monogram Orthopaedics, Inc. | 3.18 Million USD | -36102.251% |
MaxCyte, Inc. | 36.1 Million USD | -3090.337% |
NeuroOne Medical Technologies Corporation | 1.84 Million USD | -62237.181% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -270764.44% |
Orthofix Medical Inc. | 326.58 Million USD | -252.721% |
PAVmed Inc | 57.13 Million USD | -1916.093% |
Rapid Micro Biosystems, Inc. | 25.46 Million USD | -4423.956% |
RxSight, Inc. | 22.18 Million USD | -5091.703% |
Sight Sciences, Inc. | 46.43 Million USD | -2380.694% |
SI-BONE, Inc. | 61.05 Million USD | -1786.871% |
TELA Bio, Inc. | 59.16 Million USD | -1846.921% |
Treace Medical Concepts, Inc. | 113.96 Million USD | -910.744% |
Vivos Therapeutics, Inc. | 10.31 Million USD | -11063.243% |
Acutus Medical, Inc. | 54.83 Million USD | -2000.576% |
Talis Biomedical Corporation | 29.22 Million USD | -3841.743% |
Spectral AI, Inc. | 12.4 Million USD | -9189.049% |
Nano-X Imaging Ltd. | 23.13 Million USD | -4879.403% |
CVRx, Inc. | 39.28 Million USD | -2832.475% |
DIH Holding US, Inc. Warrants | 11.95 Million USD | -9533.112% |
PetVivo Holdings, Inc. | 2.42 Million USD | -47318.392% |
Bioventus Inc. | 589.79 Million USD | -95.312% |
Venus Concept Inc. | 107.1 Million USD | -975.539% |
TriSalus Life Sciences, Inc. | 51.66 Million USD | -2129.71% |
908 Devices Inc. | 37.49 Million USD | -2972.646% |
Alphatec Holdings, Inc. | 703.48 Million USD | -63.746% |
Nemaura Medical Inc. | 26.37 Million USD | -4267.124% |
NeuroPace, Inc. | 86.99 Million USD | -1224.109% |
LENSAR, Inc. | 22.4 Million USD | -5040.502% |
Apyx Medical Corporation | 52.31 Million USD | -2101.795% |
Cutera, Inc. | 518.12 Million USD | -122.329% |
STRATA Skin Sciences, Inc. | 29.32 Million USD | -3827.765% |
BioSig Technologies, Inc. | 4.68 Million USD | -24487.727% |
Anika Therapeutics, Inc. | 58.36 Million USD | -1873.607% |
ClearPoint Neuro, Inc. | 21.48 Million USD | -5260.829% |
Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 47.499% |
Axonics, Inc. | 82.35 Million USD | -1298.675% |
Outset Medical, Inc. | 190.91 Million USD | -503.376% |
IRIDEX Corporation | 24.91 Million USD | -4523.645% |
PROCEPT BioRobotics Corporation | 123.96 Million USD | -829.242% |
IRadimed Corporation | 20.73 Million USD | -5455.26% |
Tivic Health Systems, Inc. | 1.67 Million USD | -68713.321% |
INVO Bioscience, Inc. | 19.99 Million USD | -5661.126% |
Telesis Bio, Inc. | 40.87 Million USD | -2718.328% |
Viemed Healthcare, Inc. | 40.79 Million USD | -2724.046% |
Varex Imaging Corporation | 668.6 Million USD | -72.291% |
Quipt Home Medical Corp. | 136.29 Million USD | -745.19% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -32149.02% |
Pulmonx Corporation | 60.63 Million USD | -1799.754% |
Dynatronics Corporation | 11.78 Million USD | -9678.64% |
Modular Medical, Inc. | 2.27 Million USD | -50601.364% |
ReShape Lifesciences Inc. | 4.06 Million USD | -28244.857% |
Semler Scientific, Inc. | 6.27 Million USD | -18272.169% |
InMode Ltd. | 75.91 Million USD | -1417.421% |
Bruker Corporation | 2.83 Billion USD | 59.39% |
Cytosorbents Corporation | 29.98 Million USD | -3741.644% |
DexCom, Inc. | 4.19 Billion USD | 72.546% |
Align Technology, Inc. | 2.45 Billion USD | 53.047% |
Viveve Medical, Inc. | 10.84 Million USD | -10519.849% |
ZimVie Inc. | 795.85 Million USD | -44.742% |
Movano Inc. | 5.97 Million USD | -19188.932% |
Cytek Biosciences, Inc. | 104.6 Million USD | -1001.224% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -270764.44% |
DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -9533.112% |
Tandem Diabetes Care, Inc. | 639.02 Million USD | -80.264% |
Profound Medical Corp. | 12.66 Million USD | -8994.8% |
Insulet Corporation | 1.85 Billion USD | 37.918% |
enVVeno Medical Corporation | 2.43 Million USD | -47207.392% |
Surmodics, Inc. | 65.82 Million USD | -1650.049% |
iCAD, Inc. | 8 Million USD | -14297.39% |
Nuwellis, Inc. | 6.78 Million USD | -16890.192% |
Biotricity, Inc. | 35.91 Million USD | -3106.996% |
iRhythm Technologies, Inc. | 223.04 Million USD | -416.454% |
Aethlon Medical, Inc. | 2.47 Million USD | -46355.548% |
InspireMD, Inc. | 8.14 Million USD | -14048.061% |
PAVmed Inc. | 57.13 Million USD | -1916.093% |
BIOLASE, Inc. | 35.34 Million USD | -3158.841% |
Beyond Air, Inc. | 29.77 Million USD | -3768.799% |
FONAR Corporation | 57.45 Million USD | -1904.844% |
AxoGen, Inc. | 101.16 Million USD | -1038.703% |
Vivani Medical, Inc. | 25.03 Million USD | -4501.114% |
Tactile Systems Technology, Inc. | 87.79 Million USD | -1212.059% |
Inari Medical, Inc. | 209.32 Million USD | -450.309% |
UFP Technologies, Inc. | 118.04 Million USD | -875.844% |
QT Imaging Holdings, Inc. | 12.69 Million USD | -8977.149% |
Heart Test Laboratories, Inc. | 2.18 Million USD | -52600.552% |
Tenon Medical, Inc. | 5.56 Million USD | -20592.204% |
Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -64651.827% |
Co-Diagnostics, Inc. | 17.63 Million USD | -6432.423% |
AdaptHealth Corp. | 3.15 Billion USD | 63.467% |
Sintx Technologies, Inc. | 6.59 Million USD | -17372.092% |
NanoVibronix, Inc. | 2.68 Million USD | -42786.634% |
Quanterix Corporation | 78.08 Million USD | -1375.251% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -32149.02% |
Sensus Healthcare, Inc. | 4.88 Million USD | -23481.064% |
Pacific Biosciences of California, Inc. | 1.04 Billion USD | -10.264% |
TransMedics Group, Inc. | 568.84 Million USD | -102.504% |
ReWalk Robotics Ltd. | 16.68 Million USD | -6805.257% |
NeuroMetrix, Inc. | 1.33 Million USD | -86308.691% |
Hyperfine, Inc. | 9.8 Million USD | -11654.439% |
Establishment Labs Holdings Inc. | 250.24 Million USD | -360.321% |
Biomerica, Inc. | 2.66 Million USD | -43157.041% |
Bone Biologics Corporation | 831.4 Thousand USD | -138453.311% |
AVITA Medical, Inc. | 19.86 Million USD | -5698.699% |
Bluejay Diagnostics, Inc. | 1.97 Million USD | -58264.742% |
Silk Road Medical, Inc | 114.15 Million USD | -909.071% |